发明名称 In vitro activated gamma delta lymphocytes
摘要 Patients who develop increased numbers of gamma delta + cytotoxic T lymphocytes 2-6 months after allogeneic bone marrow transplantation are less likely to relapse than those who do not. The gamma delta + T cells isolated from blood of patients with increased gamma delta + T cells are CD3+CD4-CD8-CD57+, cytolytic to K562 cells, and express the V delta 1 T cell receptor phenotype. Similar gamma delta + T cells can be generated in vitro by culture of donor mononuclear cells which are enriched for gamma delta + T cells by immunomagnetic depletion of depleted of CD4+ and CD8+ cells. This gamma delta -enriched cell preparation was cultured on a combination of immobilized pan- delta monoclonal antibody and irradiated recipient B cell leukemia. After four weeks, the cultures were almost exclusively V delta 1+CD3+CD4-CD8- cells that co-expressed activation-associated antigens CD69, CD25, and HLA-DR. Furthermore, they were cytolytic against the primary leukemia obtained from the recipient and lymphoblastic leukemia cell lines, yet had minimal cytotoxicity against normal donor-derived mononuclear cells or myeloid leukemia cell lines. These observations suggest that donor-derived cytotoxic gamma delta + T cells can be generated in vitro, and may provide therapeutic potential for prevention of disease relapse.
申请公布号 AU3472800(A) 申请公布日期 2000.08.18
申请号 AU20000034728 申请日期 2000.01.27
申请人 PALMETTO RICHLAND MEMORIAL HOSPITAL 发明人 LAWRENCE S. LAMB JR.
分类号 C12N5/02;A61K35/14;A61P35/02;C12N5/0783;C12N15/07 主分类号 C12N5/02
代理机构 代理人
主权项
地址